LogicBio Therapeutics Promotes Daniel Gruskin, MD, to…
LEXINGTON, Mass., May 19, 2021-- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic…
Tag: Daniel Gruskin
Today's Top Posts
Technology Cycle Dynamics: Steering Towards Sustainable Innovation
Niranjan Gidwani Explores the Impact of Technology on Sustainability and…
